Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000025/S136

MED-EL Cochlear Implant System

Med-El Corp. · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONP000025/S136

What did the FDA approve?

The FDA record lists P000025/S136 for the MED-EL Cochlear Implant System as an approval dated 2026-10-09 under the 135 Review Track for 30-Day Notice, with the supplement reason given as Process Change - Manufacturer/Sterilizer/Packager/Supplier. The stated purpose is expanding the shelf-life of a raw material used to make the overmold of the MED-EL cochlear implants.

This is a supplement to PMA P000025, identified by the shared PMA number, and not an approval of a new device or of the full system. The record does not name the raw material, give the prior or new shelf-life, describe the overmold's function, or provide data on safety or clinical performance; the stated purpose is the agency's description of the change, not independent evidence of those outcomes.

FDA approval order statement

approval for expanding the shelf-life of a raw material used for making the overmold of the MED-EL cochlear implants
Regulatory pathway
PMA supplement
Supplement type
135 Review Track For 30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Oct 9, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P000025/S136
Regulatory pathway
PMA supplement
Applicant
Med-El Corp.
Product code
MCM
Decision code
APPR
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Applicant
Med-El Corp.
Product code
MCM
FDA device class
3

For the original device and its historical approval scope, see PMA P000025. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P000025 · Original PMA

    COMBI 40+ COCHLEAR IMPLANT SYSTEM

  2. P000025/S136 received

    Application receipt date recorded by FDA.

  3. P000025/S136 · FDA decision

    135 Review Track For 30-Day Notice

Timeline entries are records held by MedtechLedger for P000025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000025

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA approvalAug 20, 2001FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Advanced BionicsPMA supplementSep 18, 2026FDA
Advanced BionicsPMA supplementSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Med-El Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Furstenweg 77a, Innsbruck, 6020

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records